$GWLL

GOLDENWELL BIOTECH, INC.

CIK:0001800373|SEC Filings

STATEMENT OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
STATEMENT OF OPERATIONS (Unaudited) - USD ($)	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
REVENUE
Sales	$ 0	$ 0		$ 0
Service Revenue	0
COST OF REVENUES	0	0		0
GROSS PROFIT	0	0		0
OPERATING EXPENSES
General and administrative	(34,776)	(28,200)	$ (66,111)	(64,636)
Total operating expenses	(34,776)	(28,200)	(66,111)	(64,636)
Operation Income	(34,776)	(28,200)	(66,111)	(64,636)
Other Income and Expenses
Other Income			15,829
Interest Expense	(2,100)	(2,100)	(4,200)	(4,200)
Loss from Inventory Impairment	0
Income tax provision	0	0	0	0
NET LOSS	$ (36,876)	$ (30,300)	$ (54,482)	$ (68,836)
Earning per share - basic and diluted	$ 0
Weighted average number of shares outstanding - basic and diluted	99,000,000	99,000,000	99,000,000	99,000,000

STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities:
Net Loss	$ (54,482)	$ (68,836)
Non-cash interest expense	4,200	4,200
Changes in operating assets
Change in Accounts Receivable	0	0
Change in inventory deposit	0	0
Change in inventory	174,745	0
Change in Allowance for Inventory Obsoletence	(174,745)	0
Change in right of use asset	0	0
Change in Prepaid OTCQB Fee	(8,490)	(16,020)
Changed in operating liabilities
Change in Accounts Payable	0	0
Change in Unearned Sales Revenue	(1,860)	0
Change in Unearned Service Revenue	0	100,000
Change in Accrued Legal Fee	0	7,760
Change in Lease liability	0	0
Net Cash used in Operating Activities	(60,632)	27,104
Cash flows from Financing Activities:
Proceeds from the due from the related party	45,000	0
Proceeds from long-term loan	0	0
Discount on Long-term loan	0	0
Proceeds from issuance of common stock	0	0
Additional paid-capital	0	0
Stock subscription receivable	0	0
Net Cash provided by Financing Activities	45,000	0
Net change in cash	(15,632)	27,104
Cash at beginning of period	26,775	49,404
Cash at end of period	$ 11,143	$ 76,507

BALANCE SHEETS - USD ($)	Jun. 30, 2026	Dec. 31, 2025
CURRENT ASSETS
Cash	$ 11,143	$ 26,775
Inventory (related party transaction)	0	174,745
Less Allowance for Inventory Obsolescence		(174,745)
Prepaid OTCQB Fee	17,835	9,345
NONCURRENT ASSETS
Right of Use Assets	0	0
TOTAL ASSETS	28,978	36,120
CURRENT LIABILITIES
Accounts Payable	0	0
Lease Liability	0	0
Unearned Sales Revenue	0	1,860
Unearned Service Revenue	100,000	100,000
Accrued Legal Fee	0
Total Current Liabilities	100,000	101,860
NONCURRENT LIABILITIES
Due from the related party	140,588	95,588
Long-term liabilities	189,250	189,250
Less Discount on Long-term Liabilities	(2,665)	(6,865)
TOTAL LIABILITIES	427,173	379,833
STOCKHOLDERS' EQUITY
Common stock, $0.0001 par value, 300,000,000 shares authorized, 99,000,000 issued and outstanding at December 31, 2025 99,000,000 issued and outstanding at June 30, 2026	9,900	9,900
Additional paid-in capital	1,302,504	1,302,504
Retained earnings	(1,710,598)	(1,656,117)
Total stockholders' equity	(398,195)	(343,713)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 28,978	$ 36,120